Tvardi Therapeutics logo

Tvardi Therapeutics

TVRD | NASDAQ
Chart Builder DCF Calculator
$1.10
-$0.08 (-6.78%)
At close: Nov 16, 2026, 4:00 PM ET
$1.06
-$0.04 (-3.64%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.78%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.2
+8.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #656/1021 (Top 64%)

Key Statistics

Market Data

Market Cap $14.67M
1D Range
1.06 1.17
52W Range
0.79 5.00

Valuation (TTM)

PE -0.41
PB 0.95
EV/EBITDA 0.28

Valuation (NTM)

Forward PE N/A
Forward PEG 0.11
Price Target $10.00
Loading financial charts...

Profile

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcriptio...

Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Jan 31, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
4
Consensus
Hold
Price Target
$10.00
Upside
+809.09%
Buy (2)
Hold (1)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.